Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

ROHM Launches an Ultra-Compact Wireless Power Chipset for Wearables

April 28, 2026

Google Translate can now help you with pronunciation

April 28, 2026

Abstrax and Western Washington University Publish New Preclinical White Paper on Cannabis Terpenes and Behavioral Responses

April 28, 2026

Employee Performance Management Market – Global Forecast to 2030 with Strategic Disruption Through Technology, Patents, Digital, and AI Adoption

April 28, 2026

Truveta unveils Truveta Intelligence, delivering real-time insights from real-world data

April 28, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » North America Clinical Trial Supply & Logistics Market Analysis, Competition, Forecasts & Opportunities, 2019-2023 & 2024-2029
Press Release

North America Clinical Trial Supply & Logistics Market Analysis, Competition, Forecasts & Opportunities, 2019-2023 & 2024-2029

By News RoomAugust 27, 20246 Mins Read
North America Clinical Trial Supply & Logistics Market Analysis, Competition, Forecasts & Opportunities, 2019-2023 & 2024-2029
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) — The “North America Clinical Trial Supply & Logistics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F” report has been added to ResearchAndMarkets.com’s offering.

North America Clinical Trial Supply & Logistics Market was valued at USD 1.21 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 6.81% through 2029

The North America Clinical Trial Supply & Logistics market is a dynamic and rapidly evolving sector that plays a crucial role in the pharmaceutical and biotechnology industries. As one of the largest and most advanced regions in terms of clinical research, North America witnesses a robust demand for efficient and reliable supply chain solutions to support clinical trials.

The market encompasses a wide range of services, including packaging, labeling, storage, distribution, and transportation of clinical trial materials. With the increasing complexity of clinical trials and the growing emphasis on precision medicine, the need for specialized and compliant supply chain solutions has become paramount. The region’s well-established regulatory framework and infrastructure contribute to the market’s competitiveness, attracting both domestic and international players.

Key factors driving the North America Clinical Trial Supply & Logistics market include the rising number of clinical trials, advancements in biopharmaceutical research, and the increasing prevalence of chronic diseases. The adoption of innovative technologies such as temperature-controlled logistics and interactive response technologies (IRT) further enhances the efficiency and reliability of clinical trial supply chains.

The market is also influenced by the expanding scope of decentralized and virtual clinical trials, which necessitate flexible and agile supply chain solutions. As the industry continues to grapple with challenges like stringent regulatory requirements, global sourcing complexities, and the need for real-time visibility, companies in the North America Clinical Trial Supply & Logistics market are actively investing in advanced technologies and strategic partnerships to stay competitive.

Integration of Advanced Technologies

The North America Clinical Trial Supply & Logistics Market is undergoing a transformative phase, propelled by the widespread integration of advanced technologies into the supply chain ecosystem. The adoption of cutting-edge technologies is revolutionizing how pharmaceutical and biotech companies manage the logistics of clinical trials. One of the key advancements is the utilization of blockchain technology to enhance the transparency, traceability, and security of the clinical trial supply chain. Blockchain ensures an immutable and decentralized ledger, reducing the risk of data errors and enhancing the integrity of the information related to the movement of trial materials.

Artificial intelligence (AI) and machine learning are also playing a pivotal role in optimizing the clinical trial supply chain. These technologies enable predictive analytics, helping forecast demand patterns, identify potential risks, and streamline inventory management. By leveraging historical data and real-time information, AI-driven systems enhance the efficiency of the supply chain, ensuring that adequate quantities of investigational drugs and supplies are available precisely when and where they are needed. This predictive capability not only minimizes the risk of stock outs or overstock situations but also contributes to cost-effectiveness in the overall trial conduct.

The integration of Internet of Things (IoT) devices and sensors into packaging and logistics processes is enhancing the monitoring and management of clinical trial supplies. Smart packaging equipped with temperature and location sensors ensures the integrity of temperature-sensitive drugs during transportation, a critical factor in maintaining the efficacy of investigational products. Real-time monitoring allows for proactive interventions in case of deviations from specified storage conditions, reducing the likelihood of compromised trial results.

The digital transformation of the clinical trial supply chain is also fostering the development of innovative tools for tracking and managing shipments. Mobile applications and cloud-based platforms provide stakeholders with real-time visibility into the movement of trial materials, allowing for quicker decision-making and more effective collaboration among various stakeholders, including sponsors, CROs, and logistics providers.

Personalized Medicine and Targeted Therapies

The surge in personalized medicine and the development of targeted therapies are serving as powerful catalysts for the growth of the North America Clinical Trial Supply & Logistics Market. Personalized medicine, which tailors treatment strategies to individual patients based on their genetic, environmental, and lifestyle factors, has gained considerable momentum. This paradigm shift in healthcare necessitates a shift in clinical trial methodologies, with an increasing number of trials focusing on patient-specific responses to therapies. The rise of targeted therapies, designed to address specific molecular or genetic characteristics associated with certain diseases, has led to a proliferation of investigational drugs with unique requirements in terms of manufacturing, storage, and transportation.

The advent of personalized medicine and targeted therapies has introduced new complexities to the clinical trial supply chain, demanding a more flexible and adaptive logistics infrastructure. The need to manage smaller, more specialized patient populations in clinical trials requires precise and timely distribution of customized treatments. This has spurred a growing demand for advanced supply chain solutions that can handle the intricacies of personalized medicine, from the production of small batch sizes to the distribution of highly specialized therapeutic agents.

The nature of targeted therapies often involves stringent temperature and handling requirements to maintain the stability and efficacy of these drugs. The Clinical Trial Supply & Logistics Market is consequently witnessing an increased focus on temperature-controlled storage and transportation solutions, including specialized packaging with temperature-monitoring capabilities. This ensures that the integrity of these advanced therapies is maintained throughout the supply chain, from manufacturing facilities to clinical trial sites.

The dynamic landscape of personalized medicine also emphasizes the importance of patient-centric trials and decentralized trial designs, where patients may participate from diverse locations. This decentralization introduces additional logistical challenges, further underscoring the need for a sophisticated and responsive supply chain infrastructure.

Key Attributes:

Report Attribute Details
No. of Pages 130
Forecast Period 2023 – 2029
Estimated Market Value (USD) in 2023 $1.21 Billion
Forecasted Market Value (USD) by 2029 $1.78 Billion
Compound Annual Growth Rate 6.8%
Regions Covered North America

Report Scope:

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • Parexel International (MA) Corporation
  • Almac Group Inc
  • Marken LLC
  • Piramal Pharma Solutions
  • Evoke Health LLC
  • DHL International Ltd
  • FedEx Corporation
  • Packaging Coordinators Inc.

North America Clinical Trial Supply & Logistics Market, By Service:

  • Logistics & distribution
  • Storage & retention
  • Packaging, labeling, and blinding
  • Manufacturing
  • Comparator sourcing
  • other services

North America Clinical Trial Supply & Logistics Market, By Therapeutic Area:

  • Oncology
  • Cardiovascular Diseases
  • Respiratory Diseases
  • CNS And Mental Disorders
  • Others

North America Clinical Trial Supply & Logistics Market, By Phase:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

North America Clinical Trial Supply & Logistics Market, By Country:

  • United States
  • Canada
  • Mexico

For more information about this report visit https://www.researchandmarkets.com/r/bcq0cn

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • North American Clinical Trial Supply & Logistics Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

ROHM Launches an Ultra-Compact Wireless Power Chipset for Wearables

Abstrax and Western Washington University Publish New Preclinical White Paper on Cannabis Terpenes and Behavioral Responses

Employee Performance Management Market – Global Forecast to 2030 with Strategic Disruption Through Technology, Patents, Digital, and AI Adoption

Truveta unveils Truveta Intelligence, delivering real-time insights from real-world data

True Food Kitchen Coming This Summer To Boulder

YPrime Introduces AI-Powered eCOA Calculation Engine

Lotto.com® Celebrates $20,000 Colorado Cash 5 Jackpot Win with a First‑Time Player

Bila Solar Achieves ISO 9001:2015 Certification, Validating Quality Systems and Operational Maturity

United States AI Server Market Research Report 2026-2034: Expansion Driven by Artificial Intelligence Workloads Across Data Centers, Cloud Platforms, and Enterprise IT Environments

Editors Picks

Google Translate can now help you with pronunciation

April 28, 2026

Abstrax and Western Washington University Publish New Preclinical White Paper on Cannabis Terpenes and Behavioral Responses

April 28, 2026

Employee Performance Management Market – Global Forecast to 2030 with Strategic Disruption Through Technology, Patents, Digital, and AI Adoption

April 28, 2026

Truveta unveils Truveta Intelligence, delivering real-time insights from real-world data

April 28, 2026

Latest News

True Food Kitchen Coming This Summer To Boulder

April 28, 2026

YPrime Introduces AI-Powered eCOA Calculation Engine

April 28, 2026

Lotto.com® Celebrates $20,000 Colorado Cash 5 Jackpot Win with a First‑Time Player

April 28, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version